Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma

Rui Hua Xu,Wei Wei,Michal Krawczyk,Wenqiu Wang,Huiyan Luo,Ken Flagg,Shaohua Yi,William Shi,Qingli Quan,Kang Li,Lianghong Zheng,Heng Zhang,Bennett A. Caughey,Qi Zhao,Jiayi Hou,Runze Zhang,Yanxin Xu,Huimin Cai,Gen Li,Rui Hou,Zheng Zhong,Danni Lin,Xin Fu,Jie Zhu,Yaou Duan,MeiXing Yu,Binwu Ying,Wengeng Zhang,Juan Wang,Edward Zhang,Charlotte Zhang,Oulan Li,Rongping Guo,Hannah Carter,Jian-Kang Zhu,Xiaoke Hao,Kang Zhang

Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma

2017

Circulating tumour DNA is used as a biomarker for cancer diagnosis. Here, the authors identified a DNA methylation biomarker for hepatocellular carcinoma and developed diagnostic and prognostic models to predict specificity and survival of patients.

Keywords:

Nanotechnology
Methylation
Materials science
DNA methylation
Cancer
Hepatocellular carcinoma
DNA
Biomarker (medicine)
Cancer research
Carcinoma
prognostic models

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

322

Citations